Cargando…

Effects of Mindfulness-Based Therapy on Clinical Symptoms and DNA Methylation in Patients with Polycystic Ovary Syndrome and High Metabolic Risk

Polycystic ovary syndrome (PCOS) is an endocrine and metabolic disorder affecting women of reproductive age. Research has shown that epigenetic alterations such as DNA methylation may play a role in the development and progression of abnormal ovarian function and metabolic disorders in PCOS. Studies...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dema, Hana, Videtič Paska, Alja, Kouter, Katarina, Katrašnik, Mojca, Jensterle, Mojca, Janež, Andrej, Oblak, Aleš, Škodlar, Borut, Bon, Jurij
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136994/ https://www.ncbi.nlm.nih.gov/pubmed/37185702 http://dx.doi.org/10.3390/cimb45040178

Ejemplares similares

DNA Methylation Patterns in Relation to Acute Severity and Duration of Anxiety and Depression
por: Vidovič, Eva, et al.
Publicado: (2023)

‘Omics’ of suicidal behaviour: A path to personalised psychiatry
por: Kouter, Katarina, et al.
Publicado: (2021)

Machine learning as the new approach to understand biomarkers of suicidal behavior
por: Paska, Alja Videtič, et al.
Publicado: (2021)

Epigenetics in psychiatry: Beyond DNA methylation
por: Kouter, Katarina, et al.
Publicado: (2023)

BDNF methylation and mRNA expression in brain and blood of completed suicides in Slovenia
por: Ropret, Sandra, et al.
Publicado: (2021)

Depressive disorder and antidepressants from an epigenetic point of view
por: Šalamon Arčan, Iris, et al.
Publicado: (2022)

Insulin Metabolism in Polycystic Ovary Syndrome: Secretion, Signaling, and Clearance
por: Herman, Rok, et al.
Publicado: (2023)

Prolactin in Polycystic Ovary Syndrome: Metabolic Effects and Therapeutic Prospects
por: Mastnak, Lara, et al.
Publicado: (2023)

Therapeutic Potential of Glucagon-like Peptide-1 Agonists in Polycystic Ovary Syndrome: From Current Clinical Evidence to Future Perspectives
por: Jensterle, Mojca, et al.
Publicado: (2022)

An impaired glucagon-like peptide-1 response is associated with prediabetes in polycystic ovary syndrome with obesity
por: Ferjan, Simona, et al.
Publicado: (2019)

Metformin as an initial adjunct to low-dose liraglutide enhances the weight-decreasing potential of liraglutide in obese polycystic ovary syndrome: Randomized control study
por: JENSTERLE, MOJCA, et al.
Publicado: (2016)

Suicide and Changes in Expression of Neuronal miRNA Predicted by an Algorithm Search through miRNA Databases
por: Videtič Paska, Alja, et al.
Publicado: (2022)

Dynamic Intercell Communication between Glioblastoma and Microenvironment through Extracellular Vesicles
por: Krapež, Gloria, et al.
Publicado: (2022)

Assessment of Eating Disorders and Eating Behavior to Improve Treatment Outcomes in Women with Polycystic Ovary Syndrome
por: Kolnikaj, Tea Shehu, et al.
Publicado: (2022)

SLC6A4 5HTTLPR Polymorphism Affects Insulin Secretion in Patients with Polycystic Ovary Syndrome
por: Šenk, Barbara, et al.
Publicado: (2018)

Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin
por: Jensterle Sever, Mojca, et al.
Publicado: (2014)

Epigenetics of Alzheimer’s Disease
por: Nikolac Perkovic, Matea, et al.
Publicado: (2021)

Aberrant methylation patterns in cancer: a clinical view
por: Paska, Alja Videtic, et al.
Publicado: (2015)

Difference in Methylation and Expression of Brain-Derived Neurotrophic Factor in Alzheimer’s Disease and Mild Cognitive Impairment
por: Kouter, Katarina, et al.
Publicado: (2023)

MON-220 Androstendione Affects Endometrial Gene Expression Profile During Window of Implantation in Obese Infertile Women with PCOS
por: Jensterle Sever, Mojca, et al.
Publicado: (2019)

Glucagon-Like Peptide 1 and Taste Perception: From Molecular Mechanisms to Potential Clinical Implications
por: Jensterle, Mojca, et al.
Publicado: (2021)

SARS-CoV-2 Omicron symptoms and adverse effects of GLP-1 RA therapy
por: Jensterle, Mojca, et al.
Publicado: (2022)

Semaglutide in Obesity: Unmet Needs in Men
por: Jensterle, Mojca, et al.
Publicado: (2023)

Nanotechnology Meets Oncology: Nanomaterials in Brain Cancer Research, Diagnosis and Therapy
por: Zottel, Alja, et al.
Publicado: (2019)

Genetic Vulnerability as a Distal Risk Factor for Suicidal Behaviour: Historical Perspective and Current Knowledge
por: ANDRIESSEN, Karl, et al.
Publicado: (2015)

Potential of modern circulating cell-free DNA diagnostic tools for detection of specific tumour cells in clinical practice
por: Gašperšič, Jernej, et al.
Publicado: (2020)

SUN-221 Effects of Liraglutide on Obesity-Associated Functional Hypogonadism in Men: A Randomized, Testosterone Replacement Treatment-Controlled Study
por: Jensterle Sever, Mojca, et al.
Publicado: (2019)

The prevalence and characteristics of non-functioning and autonomous cortisol secreting adrenal incidentaloma after patients’ stratification by body mass index and age
por: Podbregar, Ana, et al.
Publicado: (2020)

Efficacy of GLP-1 RA Approved for Weight Management in Patients With or Without Diabetes: A Narrative Review
por: Jensterle, Mojca, et al.
Publicado: (2022)

Coding of Glioblastoma Progression and Therapy Resistance through Long Noncoding RNAs
por: Zottel, Alja, et al.
Publicado: (2020)

Nanomedicine and Immunotherapy: A Step Further towards Precision Medicine for Glioblastoma
por: Šamec, Neja, et al.
Publicado: (2020)

Dense attention network identifies EEG abnormalities during working memory performance of patients with schizophrenia
por: Perellón-Alfonso, Ruben, et al.
Publicado: (2023)

Short-term effectiveness of low dose liraglutide in combination with metformin versus high dose liraglutide alone in treatment of obese PCOS: randomized trial
por: Jensterle, Mojca, et al.
Publicado: (2017)

Genetic Variability in Antioxidative and Inflammatory Pathways Modifies the Risk for PCOS and Influences Metabolic Profile of the Syndrome
por: Herman, Rok, et al.
Publicado: (2020)

Endocrine disorders after heart transplantation: national cohort study
por: Rakusa, Matej, et al.
Publicado: (2020)

Impact of COVID-19 Pandemic on Disease Control Status and Quality of Life of Patients with Acromegaly
por: Herman, Rok, et al.
Publicado: (2022)

Brown Adipose Tissue: A New Potential Target for Glucagon-like Peptide 1 Receptor Agonists in the Treatment of Obesity
por: Hropot, Tim, et al.
Publicado: (2023)

Adrenal failure and antiphospholipid syndrome
por: Mlekuš Kozamernik, Katarina, et al.
Publicado: (2020)

Data in support of association study of the brain-derived neurotrophic factor gene SNPs and completed suicide in the Slovenian sample
por: Ropret, Sandra, et al.
Publicado: (2015)

Short term monotherapy with GLP-1 receptor agonist liraglutide or PDE 4 inhibitor roflumilast is superior to metformin in weight loss in obese PCOS women: a pilot randomized study
por: Jensterle, Mojca, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_fhhpeiasnq3jabeee7gkrl5eb8